Verrica Sues to Keep Unapproved Cataridin Drugs Off US Market (NASDAQ:VRCA)

Money and hammer, wooden gavel and dollar banknotes

krisanapong detraphiphat/Momento via Getty Images

Verrica Pharmaceutical Products (NASDAQ: VRCA) filed a lawsuit to stop Canadian drugmaker Dormer Labs from selling drugs containing cantharidin in the United States

In the lawsuit, Verrica accused Dormer of violating federal and state law by allegedly engaging in false and misleading activities

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *